Giant Cell Arteritis - Ways to Precision Medicine
NCT07084480 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2025-12-22
Summary
Long-term follow-up of aortal adverse events, as well as glucocortioid-associated adverse events in patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).
Conditions
- Giant Cell Arteritis
- Polymyalgia Rheumatic (PMR)
Sponsors & Collaborators
-
Wuerzburg University Hospital
lead OTHER
Principal Investigators
-
Michael Gernert · Wuerzburg University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-14
- Primary Completion
- 2030-07-31
- Completion
- 2033-07-31
Countries
- Germany
Study Locations
More Related Trials
-
Performance of a Fast-track Pathway for Giant Cell Arteritis Diagnosis
NCT06742671 ·Status: RECRUITING
-
Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
NCT00315393 ·Status: COMPLETED
-
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)
NCT01862068 ·Status: COMPLETED
-
Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab
NCT03745586 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy Study of Two Treatments in the Remission of Vasculitis
NCT00748644 ·Status: COMPLETED ·Phase: PHASE3
-
Giant Cell Arteritis and Differential Diagnoses Associated With Positive Temporal Artery Biopsy
NCT04554290 ·Status: COMPLETED
-
Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA)
NCT04930094 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis
NCT05329090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Rituximab in Eosinophilic Granulomatosis With Polyangiitis
NCT02807103 ·Status: COMPLETED ·Phase: PHASE3
-
Giant Cell Arteritis: Comparison Between Two Standardized Corticosteroids Tapering
NCT04012905 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
NCT02169219 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis
NCT03725202 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Immunoglobulin After Relapse in Vasculitis
NCT00307658 ·Status: TERMINATED ·Phase: PHASE3
-
Aetiology of TemporaL Arteritis Study
NCT02584517 ·Status: WITHDRAWN
-
Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis
NCT03920722 ·Status: COMPLETED ·Phase: PHASE3
-
Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.
NCT03244709 ·Status: UNKNOWN ·Phase: PHASE4
-
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
NCT06868290 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)
NCT03192969 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis
NCT06335888 ·Status: RECRUITING ·Phase: PHASE2
-
PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
NCT04664465 ·Status: RECRUITING
-
Cardiovascular Involvement in Patients With Granulomatosis With Polyangiitis
NCT03782870 ·Status: UNKNOWN
-
Tocilizumab for Patients With Giant Cell Arteritis
NCT01450137 ·Status: COMPLETED ·Phase: PHASE2
-
Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis
NCT01400464 ·Status: UNKNOWN ·Phase: PHASE4
-
An Extension Study to Evaluate Long-Term Safety of Subcutaneous (SC) Tocilizumab in Participants With Giant Cell Arteritis (GCA)
NCT03202368 ·Status: COMPLETED ·Phase: PHASE3
-
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
NCT00468208 ·Status: COMPLETED ·Phase: PHASE1/PHASE2